Bayer has completed the global acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals. “This acquisition is a milestone for Bayer and we intend to continue the expansion of our attractive over-the-counter business both through organic growth and bolt-on acquisitions,” explained Bayer CEO Dr. Marijn Dekkers. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is -2.73%. On last trading day company shares ended up $58.71. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 0.06%.
On Sep 19, Trinity Industries Inc. (NYSE:TRN) Response to States’ Removal of ET-Plus® System from QPLs: “We intend to work with state departments of transportation to answer any questions they may have with regard to the ET-Plus® System and make sure they are accurately informed regarding our product. We continue to have a high degree of confidence in the proven performance and integrity of the ET-Plus® System, which was re-affirmed for eligibility to receive reimbursement on federal-aid highway projects and for use on the National Highway System by the Federal Highway Administration in June 2014.” Trinity Industries Inc. (NYSE:TRN) shares moved down -7.71% in last trading session and ended the day at $43.12. TRN Gross Margin is 25.20% and its return on assets is 7.70%. Trinity Industries Inc. (NYSE:TRN) quarterly performance is -3.71%.
Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Shalini Sharp sold 4,000 shares of the stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $56.00, for a total value of $224,000.00. Following the transaction, the chief financial officer now directly owns 76,255 shares in the company, valued at approximately $4,270,280. On 01 October, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares moved down -2.95% and was closed at $54.93. RARE EPS growth in last 5 year was 0.00%. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) year to date (YTD) performance is 30.01%.
On September 25, WellCare Health Plans, Inc. (NYSE: WCG) announced that it has entered into a $300 million expansion of its senior unsecured credit agreement to include a term loan facility. The fully-drawn term loan facility will expire in September 2016. The original $300 million revolving credit facility, which remains undrawn, expires in November 2018, as initially set. The other principal terms of the original credit agreement are substantially unchanged. WellCare Health Plans, Inc. (NYSE:WCG) ended the last trading day at $57.20. Company weekly volatility is calculated as 3.77% and price to cash ratio as 2.25. WellCare Health Plans, Inc. (NYSE:WCG) showed a weekly performance of -8.83%.
On Sept. 25, LRAD Corporation (NASDAQ:LRAD) announced the receipt of a $640,000 order for LRAD® 100X and 1000X systems and accessories from a railroad company in Africa. The LRAD units will be used by a public agency security department to maintain safety buffers around equipment, provide warnings to potential vandals, and for crowd control. LRAD Corporation (NASDAQ:LRAD) shares increased 1.85% in last trading session and ended the day at $2.76. LRAD Gross Margin is 54.60% and its return on assets is 18.80%. LRAD Corporation (NASDAQ:LRAD) quarterly performance is 32.06%.